Status:
NOT_YET_RECRUITING
Study of the Immunomodulation in the Hidradenitis Suppurativa and Evaluation of a New Therapeutic Strategy
Lead Sponsor:
Lille Catholic University
Conditions:
Hidradenitis Suppurativa
Eligibility:
All Genders
18+ years
Brief Summary
Hidradenitis suppurativa (HS), also known as Verneuil's disease, is a chronic inflammatory dermatosis of the hair follicule located mainly in the skin folds (axillae, inguinal, submammary, etc.). Cur...
Detailed Description
Hidradenitis suppurativa (HS), also known as Verneuil's disease, is a chronic inflammatory dermatosis of the hair follicule located mainly in the skin folds (axillae, inguinal, submammary, etc.). The ...
Eligibility Criteria
Inclusion
- Inclusion criteria for HS patients :
- Adult patients (≥18 years)
- Carrier of moderate to severe (Hurley grade ≥2) hidradenitis suppurativa of classical or gluteal phenotype
- Having an indication for surgical treatment (indication for excision)
- Not receiving immunomodulatory treatments (corticotherapy, biotherapy, apremilast, retinoids) or immunosuppressive treatments (methotrexate, ciclosporin) in the 6 months before inclusion, excluding antibiotics
- Agreement to participate
- Affiliated to social security
- Inclusion criteria for control receiving abdominoplasty :
- Adult patients (≥18 years)
- With no history of hidradenitis suppurativa or lesions suggestive of hidradenitis suppurativa (recurrent fold abscesses, recurrent fold suppuration, repeated draining in fold areas)
- With an indication for abdominoplasty surgery
- Not receiving immunomodulatory treatments (corticotherapy, biotherapy, apremilast, retinoids) or immunosuppressive treatments (methotrexate, ciclosporin) in the 6 months preceding inclusion, excluding antibiotics
- Agreement to participate
- Affiliated to social security
- Criteria for non-inclusion of patients with HS :
- Immunosuppression, autoimmune disease(s), cancerous disease, or acute or chronic infectious disease
- Difficulty understanding or reading French
- Patients already included in a therapeutic interventional trial
- Patients under guardianship or curatorship
- Pregnant or breast feeding women
- Syndromic hidradenitis suppurativa, hidradenitis suppurativa of follicular phenotype
- Criteria for non-inclusion of controls receiving abdominoplasty :
- Immunosuppression, autoimmune disease(s), cancerous disease, or acute or chronic infectious disease
- Difficulty understanding or reading french
- Patients already included in a therapeutic interventional trial
- Patients under guardianship or curatorship
- Pregnant or breastfeeding women
Exclusion
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05208099
Start Date
January 1 2024
End Date
June 30 2026
Last Update
October 31 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Saint Vincent-de-Paul, Service de Dermatologie-Vénéréologie
Lille, France, 59020
2
Hôpital Saint Philibert - Service de Chirurgie Viscérale
Lomme, France, 59462